Order Article Reprints

Bao M, Hua X, Mo H, Sun Z, Xu B, Chen X, Xu M, Xu X, Song J. N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca²⁺ Pathway. Biomolecules. 2022; 12(9):1195. https://doi.org/10.3390/biom12091195

Bao, Mengni, Xiumeng Hua, Han Mo, Zhe Sun, Bo Xu, Xiao Chen, Mengda Xu, Xinjie Xu, and Jiangping Song. 2022. "N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca²⁺ Pathway" Biomolecules 12, no. 9: 1195. https://doi.org/10.3390/biom12091195

Bao, M., Hua, X., Mo, H., Sun, Z., Xu, B., Chen, X., Xu, M., Xu, X., & Song, J. (2022). N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca²⁺ Pathway. Biomolecules, 12(9), 1195. https://doi.org/10.3390/biom12091195